EVP, Head of R&DCIK 0001992260
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Randhawa SimratEVP, Head of R&D |  DNTHDianthus Therapeutics, Inc. /DE/Option exercise · 10b5-1 plan | M | — 6,249 sh | Sep 3, 2026 traded Sep 1, 2026 | |
Randhawa SimratEVP, Head of R&D |
| DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan |
| M |
| — 7,500 sh |
| Sep 3, 2026 traded Sep 1, 2026 |
| 19 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Open-market sale · 10b5-1 plan | SELL | $1.42M 13.3K sh | Sep 3, 2026 traded Sep 1, 2026 |
| 12 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Open-market sale · 10b5-1 plan | SELL | $767K 7,215 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 8 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Open-market sale · 10b5-1 plan | SELL | $273K 2,600 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 7 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | $207K 9,375 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 7 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | $136K 6,249 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 7 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | $134K 7,500 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 0 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | — 9,375 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 19 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Open-market sale · 10b5-1 plan | SELL | $380K 4,159 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 0 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | — 9,375 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 0 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | — 3,998 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 10 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | $124K 6,908 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 0 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | — 6,249 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 7 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | $34K 3,998 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 6 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | $136K 6,249 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 6 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | $207K 9,375 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 11 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Open-market sale · 10b5-1 plan | SELL | $487K 5,428 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 22 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Open-market sale · 10b5-1 plan | SELL | $1.54M 16.9K sh | Jun 2, 2026 traded Jun 1, 2026 |
| 0 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | — 6,908 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 0 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | — 5,000 sh | Mar 13, 2026 traded Mar 12, 2026 |
| 0 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | $68K 7,998 sh | Mar 13, 2026 traded Mar 12, 2026 |
| 10 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | $89K 5,000 sh | Mar 13, 2026 traded Mar 12, 2026 |
| 10 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | $181K 8,332 sh | Mar 13, 2026 traded Mar 12, 2026 |
| 13 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | $276K 12.5K sh | Mar 13, 2026 traded Mar 12, 2026 |
| 27 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Open-market sale · 10b5-1 plan | SELL | $2.76M 33.8K sh | Mar 13, 2026 traded Mar 12, 2026 |
| 0 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | — 7,998 sh | Mar 13, 2026 traded Mar 12, 2026 |
| 0 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | — 8,332 sh | Mar 13, 2026 traded Mar 12, 2026 |
| 0 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | — 12.5K sh | Mar 13, 2026 traded Mar 12, 2026 |
| 5 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Grant or award | A | — 150.0K sh | Feb 4, 2026 traded Feb 3, 2026 |
| 2 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | $63K 3,529 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 13 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | $720K 40.3K sh | Nov 14, 2025 traded Nov 14, 2025 |
| 3 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | — 31.3K sh | Nov 14, 2025 traded Nov 14, 2025 |
| 7 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | — 37.5K sh | Nov 14, 2025 traded Nov 14, 2025 |
| 7 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | — 40.3K sh | Nov 14, 2025 traded Nov 14, 2025 |
| 0 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | — 3,529 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 0 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | — 84.0K sh | Nov 14, 2025 traded Nov 13, 2025 |
| 22 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Open-market sale · 10b5-1 plan | SELL | $4.16M 109.0K sh | Nov 14, 2025 traded Nov 14, 2025 |
| 9 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | $690K 31.3K sh | Nov 14, 2025 traded Nov 14, 2025 |
| 13 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | $816K 37.5K sh | Nov 14, 2025 traded Nov 14, 2025 |
| 23 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Open-market sale · 10b5-1 plan | SELL | $701K 18.6K sh | Nov 14, 2025 traded Nov 13, 2025 |
| 26 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Open-market sale · 10b5-1 plan | SELL | $1.58M 42.8K sh | Nov 14, 2025 traded Nov 13, 2025 |
| 17 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Option exercise · 10b5-1 plan | M | $709K 84.0K sh | Nov 14, 2025 traded Nov 13, 2025 |
| 19 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Open-market sale · 10b5-1 plan | SELL | $937K 26.2K sh | Nov 14, 2025 traded Nov 13, 2025 |